Relapsed Acute Lymphoblastic Leukemia (ALL) Completed Phase 2 Trials for Bortezomib (DB00188)

Back to Relapsed Acute Lymphoblastic Leukemia (ALL)

Also known as: Acute Lymphoblastic Leukemia, in Relapse / Relapsed ALL / Relapsed Acute Lymphoblastic Leukemia / Acute, relapsed Lymphoblastic Leukemia

IndicationStatusPhase
DBCOND0069491 (Relapsed Acute Lymphoblastic Leukemia (ALL))Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs